Details for Patent: 8,747,902
✉ Email this page to a colleague
Which drugs does patent 8,747,902 protect, and when does it expire?
Patent 8,747,902 protects DYANAVEL XR, DYANAVEL XR 10, DYANAVEL XR 15, DYANAVEL XR 20, and DYANAVEL XR 5, and is included in two NDAs.
This patent has twenty-one patent family members in fourteen countries.
Summary for Patent: 8,747,902
Title: | Modified release formulations containing drug-ion exchange resin complexes |
Abstract: | An aqueous liquid suspension containing a coated drug-ion exchange resin complex comprising a core composed of an amphetamine complexed with a pharmaceutically acceptable ion-exchange resin and an uncoated amphetamine-ion exchange resin complex is provided. The coated amphetamine-ion exchange resin complex is in admixture with a polymer to form a matrix. Methods of making the coated complex and the liquid suspension are described. |
Inventor(s): | Mehta; Ketan (Cranbury, NJ), Tu; Yu-Hsing (West Windsor, NJ) |
Assignee: | TRIS Pharma, Inc. (Monmouth Junction, NJ) |
Application Number: | 14/065,842 |
Patent Claim Types: see list of patent claims | Composition; Dosage form; |
Drugs Protected by US Patent 8,747,902
International Family Members for US Patent 8,747,902
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | E536867 | ⤷ Try a Trial | |||
Australia | 2007227569 | ⤷ Try a Trial | |||
Brazil | PI0709606 | ⤷ Try a Trial | |||
Canada | 2645855 | ⤷ Try a Trial | |||
China | 101400343 | ⤷ Try a Trial | |||
China | 102488652 | ⤷ Try a Trial | |||
Denmark | 2018160 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |